Health
Researchers identify how promising therapy may work to improve adverse effects of NAFLD – News-Medical.Net
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.
Reviewed by Emily Henderson, B.Sc.Aug 26 2020
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. There are currently no approved medications for NAFLD, but in a study published in the journal JCI Insight on August 20, 2020, investigators conducted a genetic analysis that has identified how one promising t…
-
Noosa News22 hours agoChild sex offenders to be known in Queensland public registry
-
General22 hours agoThousands flood cities demanding action on Palestine
-
General21 hours agoNRLW Sunday: Brisbane Broncos hammer Newcastle Knights, Cronulla Sharks move to third on ladder
-
General13 hours agoFirst home buyers score early access to deposit scheme